FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2895960861> ?p ?o ?g. }

• W2895960861 abstract "We report here a correlation analysis conducted along with a phase II trial assessing bevacizumab in combination with weekly paclitaxel. Circulating pro/anti-angiogenic factors were assessed on day 1 (D1) and day 8 (D8). The prognostic value for progression-free survival (PFS) was evaluated using a Cox model with biomarkers as continuous variables. Among the 51 patients enrolled and treated in this trial, biomarker analysis was performed for 42: 18 in Arm A (single-agent) and 24 in Arm B (combination). With a median follow-up of 46 months, PFS was 5.5 versus 5.7 months, respectively (p = 0.75). According to univariate analysis, factors associated with a poor PFS were as follows: visceral angiosarcoma, de novo angiosarcoma, and high PlGF and low VEGF-C baseline values. In multivariate analysis, de novo angiosarcoma (HR = 2.5; p = 0.024) and baseline VEGF-C value (HR = 0.7; p = 0.003) were significant prognostic factors. We observed a significant increase in circulating PlGF (< 0.001) and a decrease in VEGF (< 0.001) during bevacizumab treatment. An increase in FGF was associated with a poor outcome. De novo angiosarcoma and a low baseline level of VEGF-C were found to be associated with a poor prognosis. Addition of bevacizumab induces major changes in circulating biomarkers (VEGF and PlGF) in a short timeframe without impacting PFS. Retrospectively registered on EudraCT N° 2009–017020-59 and NCT01303497 (February 24, 2011)." @default.
• W2895960861 created "2018-10-26" @default.
• W2895960861 creator A5000239628 @default.
• W2895960861 creator A5004551731 @default.
• W2895960861 creator A5006642161 @default.
• W2895960861 creator A5013591523 @default.
• W2895960861 creator A5018249256 @default.
• W2895960861 creator A5019114830 @default.
• W2895960861 creator A5021912565 @default.
• W2895960861 creator A5042202815 @default.
• W2895960861 creator A5052242950 @default.
• W2895960861 creator A5060949051 @default.
• W2895960861 creator A5073713547 @default.
• W2895960861 creator A5080620486 @default.
• W2895960861 creator A5090103193 @default.
• W2895960861 creator A5090781649 @default.
• W2895960861 creator A5091721810 @default.
• W2895960861 date "2018-10-11" @default.
• W2895960861 modified "2023-10-03" @default.
• W2895960861 title "Prognostic and predictive factors for angiosarcoma patients receiving paclitaxel once weekly plus or minus bevacizumab: an ancillary study derived from a randomized clinical trial" @default.
• W2895960861 cites W1226199980 @default.
• W2895960861 cites W1559201260 @default.
• W2895960861 cites W1964700247 @default.
• W2895960861 cites W1981486151 @default.
• W2895960861 cites W1983035953 @default.
• W2895960861 cites W1998405343 @default.
• W2895960861 cites W2026144900 @default.
• W2895960861 cites W2029717031 @default.
• W2895960861 cites W2033889480 @default.
• W2895960861 cites W2054058572 @default.
• W2895960861 cites W2076911447 @default.
• W2895960861 cites W2077980958 @default.
• W2895960861 cites W2095374934 @default.
• W2895960861 cites W2099186776 @default.
• W2895960861 cites W2100106896 @default.
• W2895960861 cites W2111364511 @default.
• W2895960861 cites W2118880688 @default.
• W2895960861 cites W2122730895 @default.
• W2895960861 cites W2145202379 @default.
• W2895960861 cites W2158493799 @default.
• W2895960861 cites W2161032069 @default.
• W2895960861 cites W2166738660 @default.
• W2895960861 cites W2168977372 @default.
• W2895960861 cites W2326448813 @default.
• W2895960861 cites W2626743367 @default.
• W2895960861 cites W2989800034 @default.
• W2895960861 doi "https://doi.org/10.1186/s12885-018-4828-1" @default.
• W2895960861 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6180490" @default.
• W2895960861 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30305054" @default.
• W2895960861 hasPublicationYear "2018" @default.
• W2895960861 type Work @default.
• W2895960861 sameAs 2895960861 @default.
• W2895960861 citedByCount "13" @default.
• W2895960861 countsByYear W28959608612019 @default.
• W2895960861 countsByYear W28959608612020 @default.
• W2895960861 countsByYear W28959608612021 @default.
• W2895960861 countsByYear W28959608612022 @default.
• W2895960861 countsByYear W28959608612023 @default.
• W2895960861 crossrefType "journal-article" @default.
• W2895960861 hasAuthorship W2895960861A5000239628 @default.
• W2895960861 hasAuthorship W2895960861A5004551731 @default.
• W2895960861 hasAuthorship W2895960861A5006642161 @default.
• W2895960861 hasAuthorship W2895960861A5013591523 @default.
• W2895960861 hasAuthorship W2895960861A5018249256 @default.
• W2895960861 hasAuthorship W2895960861A5019114830 @default.
• W2895960861 hasAuthorship W2895960861A5021912565 @default.
• W2895960861 hasAuthorship W2895960861A5042202815 @default.
• W2895960861 hasAuthorship W2895960861A5052242950 @default.
• W2895960861 hasAuthorship W2895960861A5060949051 @default.
• W2895960861 hasAuthorship W2895960861A5073713547 @default.
• W2895960861 hasAuthorship W2895960861A5080620486 @default.
• W2895960861 hasAuthorship W2895960861A5090103193 @default.
• W2895960861 hasAuthorship W2895960861A5090781649 @default.
• W2895960861 hasAuthorship W2895960861A5091721810 @default.
• W2895960861 hasBestOaLocation W28959608611 @default.
• W2895960861 hasConcept C126322002 @default.
• W2895960861 hasConcept C141071460 @default.
• W2895960861 hasConcept C143998085 @default.
• W2895960861 hasConcept C144301174 @default.
• W2895960861 hasConcept C168563851 @default.
• W2895960861 hasConcept C185592680 @default.
• W2895960861 hasConcept C2776694085 @default.
• W2895960861 hasConcept C2777292972 @default.
• W2895960861 hasConcept C2777802072 @default.
• W2895960861 hasConcept C2779217266 @default.
• W2895960861 hasConcept C2780140570 @default.
• W2895960861 hasConcept C2780739268 @default.
• W2895960861 hasConcept C2781197716 @default.
• W2895960861 hasConcept C38180746 @default.
• W2895960861 hasConcept C55493867 @default.
• W2895960861 hasConcept C71924100 @default.
• W2895960861 hasConceptScore W2895960861C126322002 @default.
• W2895960861 hasConceptScore W2895960861C141071460 @default.
• W2895960861 hasConceptScore W2895960861C143998085 @default.
• W2895960861 hasConceptScore W2895960861C144301174 @default.
• W2895960861 hasConceptScore W2895960861C168563851 @default.
• W2895960861 hasConceptScore W2895960861C185592680 @default.
• W2895960861 hasConceptScore W2895960861C2776694085 @default.
• W2895960861 hasConceptScore W2895960861C2777292972 @default.
• W2895960861 hasConceptScore W2895960861C2777802072 @default.

• next